{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T04:02:15Z","timestamp":1746417735810,"version":"3.40.4"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"50","license":[{"start":{"date-parts":[[2021,12,17]],"date-time":"2021-12-17T00:00:00Z","timestamp":1639699200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Chongqing social undertakings and people's livelihood security science and technology innovation special project","award":["NO. Cstc2017shmsA130069"],"award-info":[{"award-number":["NO. Cstc2017shmsA130069"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>Adrenocortical carcinoma is an invasive malignancy with poor prognosis, high recurrence rate and limited therapeutic options. Therefore, it is necessary to establish an effective method to diagnose and evaluate the prognosis of patients, so as to realize individualized treatment and improve their survival rate.<\/jats:p>\n            <jats:p>This study investigated metabolic genes that may be potential therapeutic targets for Adrenocortical carcinoma (ACC). Level 3 gene expression data from the ACC cohort and the relevant clinical information were obtained from The Cancer Genome Atlas (TCGA) database. To verify, other ACC datasets (GSE76021, GSE19750) were downloaded from the Gene Expression Omnibus (GEO) database. The ACC datasets from TCGA and GEO were used to screen metabolic genes through the Molecular Signatures Database using gene set enrichment analysis. Then, the overlapping metabolic genes of the 2 datasets were identified.<\/jats:p>\n            <jats:p>A signature of five metabolic genes (CYP11B1, GSTM2, IRF9, RPL31, and UBE2C) was identified in patients with ACC. The signature could be used to divide the patients with ACC into high- and low-risk groups based on their median risk score. Multivariate Cox regression analysis was performed to determine the independent prognostic factors of ACC. Time-dependent receiver operating characteristic (ROC) curve analysis was conducted to assess the prediction accuracy of the prognostic signature. Last, a nomogram was established to assess the individualized prognosis prediction model.<\/jats:p>\n            <jats:p>The results indicated that the signature of 5 metabolic genes had excellent predictive value for ACC. These findings might help improve personalized treatment and medical decisions.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000027864","type":"journal-article","created":{"date-parts":[[2021,12,17]],"date-time":"2021-12-17T13:10:08Z","timestamp":1639746608000},"page":"e27864","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Identification of prognostic metabolic genes in adrenocortical carcinoma and establishment of a prognostic nomogram"],"prefix":"10.1097","volume":"100","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6936-3235","authenticated-orcid":false,"given":"Qing","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Endocrinology, the Second Affiliated Hospital of Chongqing Medical University, Chongqing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziyu","family":"Ren","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, the Second Affiliated Hospital of Chongqing Medical University, Chongqing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongfang","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, the Second Affiliated Hospital of Chongqing Medical University, Chongqing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zongrui","family":"Jin","sequence":"additional","affiliation":[{"name":"Guangxi Medical University, Nanning, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuan","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, the Second Affiliated Hospital of Chongqing Medical University, Chongqing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, the Second Affiliated Hospital of Chongqing Medical University, Chongqing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qicong","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, the Second Affiliated Hospital of Chongqing Medical University, Chongqing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Cheng","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, the Second Affiliated Hospital of Chongqing Medical University, Chongqing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,12,17]]},"reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1007\/s00268-005-0329-x","article-title":"Extent of disease at presentation and outcome for adrenocortical carcinoma: have we made progress?","volume":"30","author":"Kebebew","year":"2006","journal-title":"World J Surg"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1002\/(SICI)1097-0142(20000215)88:4<711::AID-CNCR1>3.0.CO;2-W","article-title":"Adrenocortical carcinoma: clinical and laboratory observations","volume":"88","author":"Wajchenberg","year":"2000","journal-title":"Cancer"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1210\/jc.2005-2639","article-title":"Clinical review: adrenocortical carcinoma: clinical update","volume":"91","author":"Allolio","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1056\/NEJM199004263221705","article-title":"Clinical features of adrenocortical carcinoma, prognostic factors, and the effect of mitotane therapy","volume":"322","author":"Luton","year":"1990","journal-title":"N Engl J Med"},{"key":"R5-20250504","first-page":"339","article-title":"Deficits in the management of patients with adrenocortical carcinoma in Germany. Statements cannot be substantiated","volume":"108","author":"Dietel","year":"2011","journal-title":"Deutsches Arzteblatt international"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1007\/s00268-001-0030-7","article-title":"Adrenal cortical carcinoma","volume":"25","author":"Dackiw","year":"2001","journal-title":"World J Surg"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"4501","DOI":"10.1210\/jc.2006-1007","article-title":"Efficacy of adjuvant radiotherapy of the tumor bed on local recurrence of adrenocortical carcinoma","volume":"91","author":"Fassnacht","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1126\/science.123.3191.309","article-title":"On the origin of cancer cells","volume":"123","author":"Warburg","year":"1956","journal-title":"Science (New York, N Y )"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"6921","DOI":"10.1158\/0008-5472.CAN-11-1457","article-title":"Lactate: a metabolic key player in cancer","volume":"71","author":"Hirschhaeuser","year":"2011","journal-title":"Cancer Res"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"6706354","DOI":"10.1155\/2019\/6706354","article-title":"Integrative analysis reveals comprehensive altered metabolic genes linking with tumor epigenetics modification in pan-cancer","volume":"2019","author":"Shi","year":"2019","journal-title":"Biomed Res Int"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"8699","DOI":"10.1016\/S0021-9258(19)68900-3","article-title":"Energy metabolism of tumor cells. Requirement for a form of hexokinase with a propensity for mitochondrial binding","volume":"256","author":"Bustamante","year":"1981","journal-title":"J Biol Chem"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"e32996","DOI":"10.1371\/journal.pone.0032996","article-title":"Differential expression of metabolic genes in tumor and stromal components of primary and metastatic loci in pancreatic adenocarcinoma","volume":"7","author":"Chaika","year":"2012","journal-title":"PLoS One"},{"key":"R13-20250504","doi-asserted-by":"crossref","DOI":"10.1007\/s10238-020-00652-1","article-title":"Development and validation of a metabolic gene signature for predicting overall survival in patients with colon cancer","author":"Ren","year":"2020","journal-title":"Clin Exp Med"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.3389\/fimmu.2020.01218","article-title":"Pan-cancer analysis of immune cell infiltration identifies a prognostic immune-cell characteristic score (ICCS) in lung adenocarcinoma","volume":"11","author":"Zuo","year":"2020","journal-title":"Front Immunol"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S1470-2045(18)30102-5","article-title":"A gene-expression profiling score for prediction of outcome in patients with follicular lymphoma: a retrospective training and validation analysis in three international cohorts","volume":"19","author":"Huet","year":"2018","journal-title":"Lancet Oncol"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s13046-015-0219-5","article-title":"Identification and validation of potential prognostic lncRNA biomarkers for predicting survival in patients with multiple myeloma","volume":"34","author":"Zhou","year":"2015","journal-title":"J Exp Clin Cancer Res"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"4493","DOI":"10.2147\/OTT.S142557","article-title":"Genome-scale analysis to identify prognostic markers in patients with early-stage pancreatic ductal adenocarcinoma after pancreaticoduodenectomy","volume":"10","author":"Liao","year":"2017","journal-title":"Onco Targets Ther"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"116596","DOI":"10.1016\/j.lfs.2019.116596","article-title":"Identification of prognostic markers for hepatocellular carcinoma based on miRNA expression profiles","volume":"232","author":"Wang","year":"2019","journal-title":"Life Sci"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"Cluster Profiler: an R package for comparing biological themes among gene clusters","volume":"16","author":"Yu","year":"2012","journal-title":"OMICS"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1210\/er.2002-0031","article-title":"The clinically inapparent adrenal mass: update in diagnosis and management","volume":"25","author":"Mansmann","year":"2004","journal-title":"Endocr Rev"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1210\/er.2013-1029","article-title":"Adrenocortical carcinoma","volume":"35","author":"Else","year":"2014","journal-title":"Endocr Rev"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1210\/jc.2005-2730","article-title":"Clinical and biological features in the prognosis of adrenocortical cancer: poor outcome of cortisol-secreting tumors in a series of 202 consecutive patients","volume":"91","author":"Abiven","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.surg.2018.04.068","article-title":"Longitudinal patterns of recurrence in patients with adrenocortical carcinoma","volume":"165","author":"Glenn","year":"2019","journal-title":"Surgery"},{"key":"R24-20250504","first-page":"1016","article-title":"Revisiting the hallmarks of cancer","volume":"7","author":"Fouad","year":"2017","journal-title":"Am J Cancer Res"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"3713","DOI":"10.1210\/jc.2018-02686","article-title":"Transcriptome analyses identify a metabolic gene signature indicative of dedifferentiation of papillary thyroid cancer","volume":"104","author":"Ma","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"5920","DOI":"10.1158\/0008-5472.CAN-19-1405","article-title":"BRCA1 deficiency upregulates NNMT, which reprograms metabolism and sensitizes ovarian cancer cells to mitochondrial metabolic targeting agents","volume":"79","author":"Kanakkanthara","year":"2019","journal-title":"Cancer Res"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s002800050610","article-title":"Adrenal proteins bound by a reactive intermediate of mitotane","volume":"39","author":"Cai","year":"1997","journal-title":"Cancer Chemother Pharmacol"},{"key":"R28-20250504","first-page":"1319","article-title":"Cytochrome P450-catalyzed binding of 3-methylsulfonyl-DDE and o,p\u2019-DDD in human adrenal zona fasciculata\/reticularis","volume":"87","author":"Lindhe","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s12020-019-02022-8","article-title":"H-score of 11beta-hydroxylase and aldosterone synthase in the histopathological diagnosis of adrenocortical tumors","volume":"65","author":"Yang","year":"2019","journal-title":"Endocrine"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.ymthe.2019.01.001","article-title":"Analyzing the interactions of mRNAs and ncRNAs to predict competing endogenous RNA networks in osteosarcoma chemo-resistance","volume":"27","author":"Zhu","year":"2019","journal-title":"Mol Ther"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"8025","DOI":"10.1158\/0008-5472.CAN-09-1314","article-title":"Structural basis for the binding of the anticancer compound 6-(7-nitro-2,1,3-benzoxadiazol-4-ylthio) hexanol to human glutathione s-transferases","volume":"69","author":"Federici","year":"2009","journal-title":"Cancer Res"},{"key":"R32-20250504","doi-asserted-by":"crossref","first-page":"05","DOI":"10.1136\/gut.2007.146290","article-title":"DNA hypermethylation regulates the expression of members of the Mu-class glutathione S-transferases and glutathione peroxidases in Barrett's adenocarcinoma","volume":"58","author":"Peng","year":"2009","journal-title":"Gut"},{"key":"R33-20250504","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1093\/aje\/kwm315","article-title":"Genetic variants of glutathione S-transferase as possible risk factors for hepatocellular carcinoma: a HuGE systematic review and meta-analysis","volume":"167","author":"White","year":"2008","journal-title":"Am J Epidemiol"},{"key":"R34-20250504","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1084\/jem.20180628","article-title":"Life-threatening influenza pneumonitis in a child with inherited IRF9 deficiency","volume":"215","author":"Hernandez","year":"2018","journal-title":"J Exp Med"},{"issue":"(22)","key":"R35-20250504","article-title":"IRF9 prevents CD8\u200aT cell exhaustion in an extrinsic manner during acute lymphocytic choriomeningitis virus infection","volume":"91","author":"Huber","year":"2017","journal-title":"J Virol"},{"key":"R36-20250504","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41698-019-0093-2","article-title":"Tumor inherent interferon regulators as biomarkers of long-term chemotherapeutic response in TNBC","volume":"3","author":"Brockwell","year":"2019","journal-title":"NPJ Precis Oncol"},{"key":"R37-20250504","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/bjh.16508","article-title":"A 20-year long term experience of the Italian Diamond-Blackfan Anaemia Registry: RPS and RPL genes, different faces of the same disease?","volume":"190","author":"Quarello","year":"2020","journal-title":"Br J Haematol"},{"key":"R38-20250504","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1093\/annonc\/mdr527","article-title":"Prognostic significance of UBE2C mRNA expression in high-risk early breast cancer. A hellenic cooperative oncology group (HeCOG) study","volume":"23","author":"Psyrri","year":"2012","journal-title":"Ann Oncol"},{"key":"R39-20250504","doi-asserted-by":"crossref","first-page":"847","DOI":"10.3389\/fphar.2018.00847","article-title":"UBE2C is a potential biomarker of intestinal-type gastric cancer with chromosomal instability","volume":"9","author":"Zhang","year":"2018","journal-title":"Front Pharmacol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000027864","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T05:19:16Z","timestamp":1746335956000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000027864"}},"subtitle":["A bioinformatic study"],"short-title":[],"issued":{"date-parts":[[2021,12,17]]},"references-count":39,"journal-issue":{"issue":"50","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000027864","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"type":"print","value":"0025-7974"},{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2021,12,17]]},"assertion":[{"value":"2021-03-21","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-11-03","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}